169 related articles for article (PubMed ID: 27490766)
1. The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.
Wolsky RJ; Harbour LN; Mirza KM; Montag AG; Gwin K
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):403-410. PubMed ID: 27490766
[TBL] [Abstract][Full Text] [Related]
2. Association of P16, Ki-67, and CD44 expression in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of the cervix.
Mehdi HK; Raju K; Sheela SR
J Cancer Res Ther; 2023 Apr; 19(Supplement):S260-S267. PubMed ID: 37148002
[TBL] [Abstract][Full Text] [Related]
3. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
4. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
5. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
6. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
8. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
9. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
10. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
11. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
[TBL] [Abstract][Full Text] [Related]
12. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
13. p16 Expression and Biological Behavior of Flat Vulvar Low-grade Squamous Intraepithelial Lesions (LSIL).
Lewis N; Blanco LZ; Maniar KP
Int J Gynecol Pathol; 2017 Sep; 36(5):486-492. PubMed ID: 28719486
[TBL] [Abstract][Full Text] [Related]
14. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
15. p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies.
Cheah PL; Looi LM; Teoh KH; Mun KS; Nazarina AR
Asian Pac J Cancer Prev; 2012; 13(2):469-72. PubMed ID: 22524808
[TBL] [Abstract][Full Text] [Related]
16. Association of p16 and Ki-67 with Risk of Recurrence in Previously Treated Cervical High-Grade Squamous Intraepithelial Lesions.
Arredondo-Gálvez CG; Acuña-González D; Cantú-de-León D; Chanona-Vilchis JG; Avilés-Salas A; González-Enciso A; Bandala-Jaques A; Barquet-Muñoz SA
Gynecol Obstet Invest; 2021; 86(3):293-298. PubMed ID: 34111875
[TBL] [Abstract][Full Text] [Related]
17. Test Characteristics of Specific p16 Clones in the Detection of High-grade Squamous Intraepithelial Lesions (HSIL).
Shain AF; Wilbur DC; Stoler MH; Quade BJ; Kong CS
Int J Gynecol Pathol; 2018 Jan; 37(1):82-87. PubMed ID: 28863068
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.
Kisser A; Zechmeister-Koss I
BJOG; 2015 Jan; 122(1):64-70. PubMed ID: 25208923
[TBL] [Abstract][Full Text] [Related]
19. Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions.
Samarawardana P; Singh M; Shroyer KR
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):514-8. PubMed ID: 21602668
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of variable p16 immunostaining patterns, Ki-67 indices and HPV status in cervical SILs and squamous cell carcinomas: An institutional experience.
Singh P; Kaushik S; Thakur B; Acharya S; Bhardwaj A; Bahal N
Indian J Pathol Microbiol; 2023; 66(1):63-69. PubMed ID: 36656212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
